Three-year Outcomes of Endothelial Keratoplasty in Late-Stage Elderly Versus Younger Patients Authors: Masatoshi Hirayama, Risa Yamazaki-Hokama, Takanori Suzuki, Kazuno Negishi Published: 2025 ABSTRACT AbstractPurposeThis study aimed to report the 3-year clinical outcomes of corneal endothelial keratoplasty (EK) in late-stage elderly patients (≥75 years) compared with younger patients (<75 years).Study DesignRetrospective observational study.MethodsPatients who underwent EK, including Descemet’s stripping automated keratoplasty (DSAEK) and non-Descemet stripping and automated endothelial keratoplasty (nDSAEK) with bullous keratopathy (BK) at Keio University Hospital between 2016 and 2018, were included. Patient characteristics, graft survival rate, best corrected visual acuity (BCVA), corneal endothelial cell density (ECD), and complications were compared between the late elderly group (75 years or older) and the younger group (<75 years old) stratified by surgical procedure.ResultsAmong the 64 eyes and 55 patients who underwent EK, 31 eyes and 30 patients were in the late elderly group (81.4±3.7 years), and 33 eyes and 25 patients were in the younger group (66.2±9.1 years). There was no difference between the groups in terms of the cause of BK, and PBK was more common in the DSAEK group in the late elderly group (p = 0.029). There was no difference in graft survival between the two groups during the follow-up period. In the late elderly group, graft survival was significantly better in the nDSAEK group than in the DSAEK group (p = 0.045). BCVA and postoperative ECD improved in both groups. There were no differences in intraoperative or postoperative complications between the late elderly and younger groups.ConclusionEK for BK in late elderly patients resulted in postoperative visual improvement, with similar efficacy and safety to those of EK for BK in younger patients.Keywords: bullous keratopathy, aging, Descemet’s stripping automated endothelial keratoplasty, non-descemet stripping and automated endothelial keratoplasty Introduction Bullous keratopathy (BK) has been the leading indication for corneal transplantation in the United States and Canada over the past 34 years.1 For almost a century, penetrating keratoplasty (PK) was the standard surgical procedure for treating BK; however, in recent decades, endothelial keratoplasty (EK) has become the preferred approach because it allows faster visual recovery, requires smaller incisions, and reduces postoperative astigmatism and graft rejection.2 EK encompasses Descemet’s stripping automated EK (DSAEK), non-Descemet stripping EK (nDSAEK), and Descemet membrane EK (DMEK). According to the Eye Bank Association of America, 89% of eyes with corneal endothelial dysfunction were treated with EK and only 11% with PK in 2019 (2019 Eye Banking Statistical Report Eye Bank Association of America, Washington, D.C (2020), p. 19). DMEK has rapidly become the predominant procedure in Western countries, whereas in Japan, DSAEK and nDSAEK are still most commonly performed, with limited adoption of DMEK.3 When considering EK in elderly patients, ophthalmological characteristics such as a shallow anterior chamber or a history of glaucoma surgery,4,5 as well as systemic and functional aspects including cognitive and physical status,6 must be carefully evaluated,7 and surgical risk assessment in older patients is crucial for decision-making.8 Particularly in late-stage elderly patients (≥75 years, according to the Japan Geriatrics Society and the World Health Organization), prolonged hospitalization and postoperative positioning after EK, such as supine rest following air injection for graft attachment, may represent a physical burden.9–11 In addition, it has been reported that repeat PK generally shows poorer long-term prognosis compared with primary PK,12 which historically influenced surgical choice. Nevertheless, with the advent of a longevity society and the increasing role of EK, few studies have reported the long-term outcomes of EK in late-stage elderly patients. Therefore, this study aimed to evaluate the 3-year outcomes of EK including DSAEK and nDSAEK, in late-stage elderly patients compared with younger patients. Methods Ethics and Patient Profiles This retrospective study was approved by the institutional review board of Keio University School of Medicine (Approval number 20190130). This retrospective study was approved by the Institutional Review Board of Keio University School of Medicine (Approval number 20190130). Because of the retrospective design, written informed consent was waived; instead, information regarding the study was disclosed publicly, and patients were provided the opportunity to decline participation (opt-out method). The study adhered to the tenets of the Declaration of Helsinki, and all data were anonymized to protect patient confidentiality. Our study had limitations since it was retrospective, and the number of cases in each group declined over time due to patients lost to follow-up, making it difficult to secure a sufficient number of cases with complete data at the 3-year time point. To achieve adequate follow-up duration, it was necessary to include medical records from before 2018. Sixty-four eyes of 55 patients with BK who received corneal endothelial keratoplasty (DSAEK or nDSAEK) from January 2016 to December 2018 at Keio University Hospital were included in this study. Postoperative follow-up was routinely scheduled at 3 months, 6 months, 1 year, 2 years, and 3 years. This protocol reflects our institutional standard of care, with visits every 3 months until 6 months, every 6 months until 1 year, and annually thereafter. These intervals are also commonly used in previously published reports of endothelial keratoplasty. Cases without data at a given time point were considered missing and were not included in the analysis for that interval. The selection of surgical technique has been determined by whether the patient has Fuchs corneal endothelial dystrophy. nDSAEK has been our preferred approach for patients without Fuchs dystrophy whenever feasible. In this study, “late elderly” was defined as individuals aged 75 years or older, in accordance with the classification proposed by the Japan Geriatrics Society and the World Health Organization (WHO), corresponding to the “old-old” or more advanced age subgroup recognized in gerontological classifications. The patients were classified into a late elderly group (≥75 years old) and a younger group (< 75 years old), as shown in Table 1. In the late elderly group (31 eyes of 30 patients), the average age was 81.4 ± 3.7 years, the male to female ratio was 8:22, and the details of the surgical procedure were DSAEK in 11 eyes and nDSAEK in 18 eyes. In the younger group (33 eyes of 25 patients), the average age was 66.2 ±9.1 years, the male-to-female ratio was 8:17, and the details of the surgical procedure were DSAEK in 10 eyes and nDSAEK in 23 eyes, as described in Table 1. We enrolled all patients with EK during the study period. Table 1Patient Demographics of Young and Elderly Group with Endothelial KeratoplastyElderly Group (≧75 yo)Younger GroupNumber (eyes/cases)31/3033 / 25Male: Female (eyes)8:228:17Age (y.o.)81.4±3.7*66.2±9.1Causes (eyes, %)PBK15 (48.4)11 (33.3)LIBK6 (19.4)7 (21.2)FECD3 (9.7)6 (18.2)regraft3 (9.7)2 (6.1)Post-glaucoma surgery2 (6.5)3 (9.1)CMV infection1 (3.2)NAAniridiaNA1 (3.0)ASMDNA1 (3.0)TraumaNA1 (3.0)Shallow AC1 (3.2)1 (3.0)Surgeries (eyes, %)DSAEK12 (38.7)10 (30.3)with triple procedure1 (3.7)NAnDSAEK18 (58.1)22 (66.7)with triple procedureNA1 (3.0)Note: * p<0.001 compared between groups (Welch’s t-test).Abbreviations: PBK, Pseudophakic bullous keratopathy; LIBK, Argon laser iridotomy induced bullous keratopathy; FECD, Fuch’s endothelial corneal dystrophy; ASMD, Anterior segment mesenchymal dysgenesis; CMV, Cytomegalovirus; AC, Anterior chamber. Patient Demographics of Young and Elderly Group with Endothelial Keratoplasty Note: * p<0.001 compared between groups (Welch’s t-test). Abbreviations: PBK, Pseudophakic bullous keratopathy; LIBK, Argon laser iridotomy induced bullous keratopathy; FECD, Fuch’s endothelial corneal dystrophy; ASMD, Anterior segment mesenchymal dysgenesis; CMV, Cytomegalovirus; AC, Anterior chamber. Surgical Techniques for Keratoplasty DSAEK and nDSAEK EK was performed under topical (4% xylocaine) and sub-Tenon (2% xylocaine) anesthesia. A 2.75-mm temporal limbal-corneal incision was made, and for the DSAEK surgery, the Descemet membrane was mechanically scraped (8.0 mm in diameter) via a modified Price-Sinskey hook (ASICO) with infusion fluids into the anterior chamber (AC) through a 25-gauge cannula at the 6:00 position. In nDSAEK surgery, Descemet membrane stripping was not performed.13 The temporal corneal incision was enlarged to 4.2 mm in width. The donor endothelial graft was inserted into the AC via the pull-through technique via a Busin glide (Moria) or NS Endo-inserter (Hoya, Tokyo, Japan). While a graft with a Busin glide was inserted, a trimmed IOL implantation sheet glide (model GLDE10; Alcon Laboratories) was inserted into the AC through a 4.2-mm incision to prevent iris prolapse. After the temporal incision was sutured with a single 10–0 nylon suture, the graft was then attached to the recipient cornea by full air injection. After surgery, all patients were instructed to maintain strict supine positioning for the first 3 hours, followed by continued bed rest in the supine position for 24 hours. Thereafter, patients were advised to avoid prone positioning as long as intracameral air persisted. In addition, a peripheral iridectomy (PI) was routinely performed in all cases as part of our standard surgical protocol to prevent pupillary block. Patients were given topical levofloxacin and topical dexamethasone 5 times a day for 3 months. Three months after surgery, patients were given topical fluorometholone 5 times a day. No systemic immunosuppressants were used. Pre- and Postoperative Data Analysis We assessed clinical outcomes, including intra- and postoperative complications, graft survival rates, best-corrected visual acuity (BCVA), and ECD preoperatively and at 3, 6, 12, and 36 months postoperatively.14 The BCVA was measured with spectacle correction via a standard Snellen chart. The results were converted into logarithms of the minimal angle of resolution (logMAR), and logMAR values of 2.0, 2.3, 2.6, and 2.9 were assigned for counting fingers (CF), hand motion (HM), light perception (LP), and no LP (NLP), respectively.15,16 The ECD was measured via a noncontact specular microscope (Noncon Robo SP-8000, Konan, Hyogo, Japan). We assessed postoperative status as follows.14 A double chamber was defined as postoperative detachment of the DM from the corneal graft. Graft rejection was defined as the presence of decreased vision, acute stromal edema, subepithelial infiltrates, or anterior chamber inflammation. Secondary glaucoma was defined as an intraocular pressure (IOP) > 20 mm Hg, presence of glaucomatous visual field defects, or postoperative onset of a C/D ratio exceeding 0.6. Graft failure was defined as decompensation with irreversible corneal edema due to a decrease in ECD < 500 cells/mm2 or irreversible opacification of the graft, preventing recovery of useful vision or a decrease in vision by more than two lines.14 Statistical Analysis The data were analyzed via Prism for Windows v.6.04 (GraphPad Software, San Diego, California, USA). To compare BCVA and ECD, we performed the Wilcoxon signed-rank sum test (for in-group comparisons) or the Mann–Whitney U-test (for between-group comparisons). The Kaplan–Meier method was used to analyze the graft survival rate. Fisher’s exact test was used to analyze the differences in patient demographics and the incidence of postoperative complications among the groups. The data are presented as the means ± SDs. Statistical significance was set at p <0.05. Results Patient Demographics In the comparison between the late elderly group and the younger group, no significant differences were observed in the number of cases, sex ratio, or distribution of causes, except for age (Table 1). The distributions of causes were subsequently compared between the late elderly and younger groups, stratified by the DSAEK and nDSAEK procedures (Tables 2 and 3). In the late elderly group, the proportion of PBK was significantly greater in the nDSAEK group than in the DSAEK group (p = 0.029, Fisher’s exact test). On the other hand, in the younger group, Fuchs’ corneal endothelial dystrophy was significantly more prevalent in the DSAEK group than in the nDSAEK group (Fuchs’ corneal endothelial dystrophy; p < 0.001, PBK; p = 0.013 Fisher’s exact test). Table 2Causes of Bullous Keratopathy in the Elderly Group Stratified by Surgical ProcedureElderly Group(Eyes, %)DSAEK (N=13)nDSAEK (N=18)PBK*3 (23.1)12 (66.6)LIBK2 (15.4)4 (22.2)FECD3 (23.1)0Regraft3 (23.1)0Post-glaucoma surgery2 (15.4)0CMV infection01 (5.6)Shallow AC01 (5.6)Note: * p=0.029 compared between groups (Fisher’s exact test).Abbreviations: DSAEK, Descemet stripping automated endothelial keratoplasty; nDSAEK, non-Descemet stripping and automated endothelial keratoplasty; PBK, Pseudophakic bullous keratopathy; LIBK, Argon laser iridotomy induced bullous keratopathy; FECD, Fuch’s endothelial corneal dystrophy; ASMD, Anterior segment mesenchymal dysgenesis; CMV, Cytomegalovirus; AC, Anterior chamber. Causes of Bullous Keratopathy in the Elderly Group Stratified by Surgical Procedure Note: * p=0.029 compared between groups (Fisher’s exact test). Abbreviations: DSAEK, Descemet stripping automated endothelial keratoplasty; nDSAEK, non-Descemet stripping and automated endothelial keratoplasty; PBK, Pseudophakic bullous keratopathy; LIBK, Argon laser iridotomy induced bullous keratopathy; FECD, Fuch’s endothelial corneal dystrophy; ASMD, Anterior segment mesenchymal dysgenesis; CMV, Cytomegalovirus; AC, Anterior chamber. Table 3Causes of Bullous Keratopathy in the Younger Group Stratified by Surgical ProcedureYounger Group(Eyes, %)DSAEK (N=10)nDSAEK (N=23)PBK*011 (47.8)LIBK2 (20.0)5 (21.7)FECD☨6 (60.0)0Regraft1 (10.0)1 (4.3)Post-glaucoma surgery1 (10.0)2 (8.7)Aniridia01 (4.3)ASMD01 (4.3)Trauma01 (4.3)Shallow AC01 (4.3)Notes: * p=0.013 ☨p<0.001 compared between groups (Fisher’s exact test).Abbreviations: DSAEK, Descemet stripping automated endothelial keratoplasty; nDSAEK, non-Descemet stripping and automated endothelial keratoplasty; PBK, Pseudophakic bullous keratopathy; LIBK, Argon laser iridotomy induced bullous keratopathy; FECD, Fuch’s endothelial corneal dystrophy; ASMD, Anterior segment mesenchymal dysgenesis; CMV, Cytomegalovirus; AC, Anterior chamber. Causes of Bullous Keratopathy in the Younger Group Stratified by Surgical Procedure Notes: * p=0.013 ☨p<0.001 compared between groups (Fisher’s exact test). Abbreviations: DSAEK, Descemet stripping automated endothelial keratoplasty; nDSAEK, non-Descemet stripping and automated endothelial keratoplasty; PBK, Pseudophakic bullous keratopathy; LIBK, Argon laser iridotomy induced bullous keratopathy; FECD, Fuch’s endothelial corneal dystrophy; ASMD, Anterior segment mesenchymal dysgenesis; CMV, Cytomegalovirus; AC, Anterior chamber. Graft Survival As shown in Figure 1a, in the late elderly group, the postoperative graft survival rate was 93.6% 1 month after surgery, 90.1% 3 months and 6 months after surgery, 82.9% 1 year after surgery, and 73.7% 2 years and 3 years after surgery. In the younger group, the postoperative graft survival rate was 100% 1 month after surgery, 87.8% 3 months and 6 months after surgery, 84.0% 1 year after surgery, 79.8% 2 years after surgery, and 66.5% 3 years after surgery. There was no significant difference in the survival rate between the late elderly group and the younger group (p = 0.85, Log rank test). Graft survival rate of EK in elderly and younger groups. (a) Graft survival rate of EK in elderly and younger groups. There was no significant difference between groups. (b) Graft survival rate of DSAEK and nDSAEK in elderly group. There was a significant difference between groups. (c) Graft survival rate of DSAEK and nDSAEK in younger group. There was no significant difference between groups. Abbreviations: DSAEK, Descemet stripping automated endothelial keratoplasty; nDSAEK, non-Descemet stripping and automated endothelial keratoplasty. The graft survival rates were subsequently compared between the DSAEK and nDSAEK procedures in both groups (Figure 1b and c). Interestingly, the graft survival rate in the nDSAEK group was significantly better than that in the DSAEK group in the late elderly group (p = 0.045, Log rank test). On the other hand, in the younger group, no significant difference in graft survival rates was observed between the DSAEK and nDSAEK groups (p = 0.42, Log rank test). Visual Outcome In this study, all eyes were pseudophakic during the postoperative period, with the exception of a single nDSAEK case in the younger group. The average postoperative BCVA improved significantly at 1 month after surgery and subsequently (p < 0.001 at any time point in the younger group; at 1, 3, and 6 months; and at 1 year [p < 0.001], 2 years [p = 0.0049], and 3 years [p = 0.018] after surgery in the late elderly group; Wilcoxon signed-rank test). There were no significant differences in BCVA among the groups (at each time point; Mann‒Whitney U-test) (Figure 2a). Changes in average BCVA before and after surgery. (a) Changes in average BCVA before and after EK in elderly and younger groups. (b) Changes in average BCVA before and after DSAEK and nDSAEK in the elderly group. (c) Changes in average BCVA before and after DSAEK and nDSAEK in the younger group. † p<0.05 compared with preoperative BCVA. * p<0.05 compared between groups. Abbreviations: DSAEK, Descemet stripping automated endothelial keratoplasty; nDSAEK, non-Descemet stripping and automated endothelial keratoplasty; BCVA, Best corrected visual acuity. In the late elderly group, a statistically significant difference was observed between the DSAEK and nDSAEK groups at 1 month postsurgery (1 M) (p = 0.046, Mann‒Whitney U-test); however, no significant differences were found at any other time point (Figure 2b). In the younger group, while the DSAEK group tended to have better BCVA at 3 years postoperatively (p = 0.10, Mann‒Whitney U-test), no statistically significant differences were observed at any time point (Figure 2c). Endothelial Cell Density Figure 3a shows the postoperative time course of ECD. No significant decrease in ECD was observed in the late elderly group after surgery. There was a significant decrease in the ECD at 2 years and 3 years after surgery in the younger group compared with the ECD at 1 month after surgery (p = 0.0028 at 2 years, p = 0.0014 at 3 years after surgery; Mann‒Whitney U-test). The average postoperative ECD exceeded 1000 cells/mm2 in both groups at any time point. There were no significant differences in postoperative ECD between the late elderly and younger groups at any time point. Changes in postoperative ECD. (a) Changes in postoperative ECD after EK in elderly and younger groups. (b) Changes in postoperative ECD after DSAEK and nDSAEK in the elderly group. (c) Changes in postoperative ECD after DSAEK and nDSAEK in the younger group. † p<0.05 compared with postoperative 1 month. Abbreviations: DSAEK, Descemet stripping automated endothelial keratoplasty; nDSAEK, non-Descemet stripping and automated endothelial keratoplasty; ECD, Endothelial cell density. As shown in Figure 3b and c, the ECD at any postoperative time point was not significantly different between DSAEK and nDSAEK in either group. Intraoperative and Postoperative Complications Table 4 shows the intra- and postoperative complications. Early postoperative complications included a double chamber in 6 (19.4%) eyes in the late elderly group and 7 (21.2%) in the younger group, which was improved by injecting air into the anterior chamber in all eyes. At baseline, patients with pre-existing glaucoma were those with a history of glaucoma surgery. All of these eyes had well-controlled intraocular pressure with topical medications at the time of keratoplasty (Table 1). Four (12.9%) eyes in the late elderly group and 8 (24.2%) in the younger group developed secondary glaucoma. Two eyes in the late elderly group and 3 eyes in the younger group needed glaucoma surgery, including trabeculectomy, trabeculotomy and/or tube shunt, but the IOP was controlled by decreasing the use of topical steroids in other patients. The incidence of post operative glaucoma in the younger group was not significantly greater than that in the late elderly group (p=0.20, Fisher’s exact test). Infectious keratitis occurred in 2 (6.5%) eyes due to Candida sp. in one eye and unknown causative organisms in the other eye; these patients were diagnosed with bacterial infections on the basis of their clinical history and slit-lamp findings. In eyes with infectious keratitis, graft clarity decreases after treating the stromal scar, which necessitates penetrating keratoplasty. Primary graft failure was observed in 1 (3.2%) eye in the late elderly group and 2 (6.1%) eyes in the younger group, which needed regrafting. No cases of graft rejection occurred in either group. Table 4Summary of Intra and Postoperative Complicationsa) Intra and postoperative complications of EK in elderly and younger groups(Eyes, %)Elderly groupYounger groupDouble chamber6 (19.4)7 (21.2)Graft dislocation1 (3.2)0Glaucoma4 (12.9)8 (24.2)Infectious keratitis2 (6.5)0PCO1 (3.2)0ERM1 (3.2)1 (3.0)Air block02 (6.1)PGF1 (3.2)2 (6.1)Iris hemo01 (3.0)Ptosis2 (6.5)2 (6.1)b) Intra and postoperative complications of DSAEK and nDSAEK in elderly and younger groupsElderly groupYounger group(Eyes, %)DSAEKnDSAEKDSAEKnDSAEKDouble chamber3 (23.1)3 (16.7)3 (30.0)4 (17.4)Graft dislocation01 (5.6)00Glaucoma1 (7.7)3 (16.7)1 (10.0)7 (30.4)Infectious keratitis1 (7.7)1 (5.6)00PCO1 (7.7)000ERM01 (5.6)01 (4.3)Air block001 (10.0)1 (4.3)PGF01 (5.6)1 (10.0)1 (4.3)Iris hemo001 (10.0)0Ptosis2 (15.4)01 (10.0)1 (4.3)Abbreviations: DSAEK, Descemet stripping automated endothelial keratoplasty; nDSAEK, non-Descemet stripping and automated endothelial keratoplasty; PCO, Post capsule opacification; ERM, Epiretinal membranes; PGF, Primary graft failure. Summary of Intra and Postoperative Complications Abbreviations: DSAEK, Descemet stripping automated endothelial keratoplasty; nDSAEK, non-Descemet stripping and automated endothelial keratoplasty; PCO, Post capsule opacification; ERM, Epiretinal membranes; PGF, Primary graft failure. There were no significant differences in the incidence of intra- or postoperative complications between the younger and late elderly groups. The incidence rates of intra- and postoperative complications in the younger and late elderly groups, stratified by the DSAEK and nDSAEK procedures, are summarized in Table 4. The incidence of glaucoma in the younger nDSAEK group was 30.4%; however, the results revealed no statistically significant differences among the groups (younger nDSAEK group vs younger DSAEK group: p = 0.382; younger nDSAEK group vs late elderly DSAEK group: p = 0.213; younger nDSAEK group vs late elderly nDSAEK group: p = 0.467; Fisher’s exact test). There was no significant difference in the incidence of glaucoma or other complications between the nDSAEK group and the younger group (p = 0.375, Fisher’s exact test). Discussions Although endothelial keratoplasty (EK) has been widely performed and studied,17,18 evidence focusing specifically on late-stage elderly patients remains scarce. The present study is, to our knowledge, one of the few investigations to evaluate 3-year clinical outcomes of EK in patients aged ≥75 years compared with younger patients. By analyzing graft survival, best-corrected visual acuity (BCVA), endothelial cell density (ECD), and postoperative complications, our results demonstrate that EK can be safely and effectively performed in late elderly patients. This provides novel and clinically relevant insights that add to the existing literature and helps guide surgical decision-making in the context of an aging population. In the context of an aging society, the limitations of penetrating keratoplasty (PK), particularly its poor prognosis in regrafts, remain a concern in the treatment of bullous keratopathy (BK) in elderly patients. While PK remains a surgical option, our study did not include direct comparative data with PK. Therefore, the findings should be interpreted specifically in the context of EK, which is increasingly adopted in Japan. Our results suggest that EK can offer comparable outcomes in late elderly patients, supporting its role as a first-line procedure even in this age group. With the rapid acceleration of population aging in Japan, providing clinical evidence specifically targeting the late elderly population has become increasingly important. According to the Cabinet Office, individuals aged ≥65 years accounted for 29.1% of the total population in 2022, with those ≥75 years numbering 19.37 million (https://www8.cao.go.jp/kourei/whitepaper/w-2023/html/zenbun/index.html). In geriatric medicine, individuals aged ≥75 years are defined as “late-stage elderly”, a group characterized by reduced activities of daily living (ADL).19,20 In our study, nearly half of the EK cases were in this age group, underscoring its clinical relevance. From a surgical perspective, minimally invasive procedures such as EK are particularly valuable in elderly patients because they reduce physical burden and allow earlier recovery and reintegration into daily life, thereby preserving quality of life (QOL) and extending healthy life expectancy.21 Compared with PK, EK offers advantages including smaller incisions, reduced astigmatism due to the absence of sutures, faster visual rehabilitation, and lower risk of rejection.22 These features are especially beneficial in late elderly patients, yet there have been few reports specifically addressing their prognosis after EK.23 Our findings demonstrate that, despite potential concerns regarding postoperative positioning and physical tolerance,24 EK can be successfully performed with favorable outcomes in late elderly patients. In addition, while DMEK has become the predominant EK procedure in the United States and Europe, its adoption in Japan remains limited, with DSAEK and nDSAEK still the most commonly performed procedures.3 This regional difference in surgical practice should be considered when interpreting the international relevance of our findings. Regarding surgical techniques, we preferentially performed nDSAEK in patients without Fuchs’ endothelial corneal dystrophy. In the elderly group, graft survival was significantly higher with nDSAEK than with DSAEK, while no such difference was observed in younger patients. This may be attributable to the less invasive nature of nDSAEK, in which Descemet’s membrane is not peeled, and to differences in underlying disease distribution, including a higher proportion of PBK in the elderly nDSAEK group.25 These findings provide the first clinical evidence supporting nDSAEK as a useful option in late elderly patients. However, this finding should be interpreted with caution because the elderly DSAEK group included a higher proportion of eyes with a history of glaucoma surgery or regrafts, both of which are well-known risk factors for poor endothelial keratoplasty outcomes. This imbalance likely confounded the results, and thus the apparent superiority of nDSAEK may in part reflect differences in baseline characteristics rather than the surgical procedure itself. Therefore, our subgroup analysis should be considered exploratory and hypothesis-generating, requiring validation in larger and more balanced cohorts. With respect to postoperative complications, no significant differences were found between elderly and younger groups. The most common events were double chamber formation and transient intraocular pressure elevation, while steroid-induced glaucoma tended to occur more frequently in younger patients, consistent with previous reports.26,27 These results indicate that EK has a comparable safety profile across age groups. However, it should be noted that none of the elderly patients in this study presented with severe cognitive impairment or advanced ADL decline. The favorable outcomes may therefore reflect careful preoperative selection, and EK may be less suitable for elderly patients unable to adhere to postoperative positioning requirements.28 This study has several limitations. First, it was a retrospective single-center study with a relatively small sample size, which may limit the generalizability of the findings. Second, subgroup comparisons between DSAEK and nDSAEK were limited by small numbers and baseline imbalances. In particular, 38% of eyes in the elderly DSAEK group had a history of glaucoma surgery or were regrafts, both of which are known risk factors for poor outcomes. This imbalance may have confounded the observed difference in graft survival between DSAEK and nDSAEK. Therefore, the subgroup findings should be considered exploratory and hypothesis-generating, requiring confirmation in larger and more balanced cohorts. In our study, the mean BCVA improved significantly at 1 month after EK. Previous studies have shown that visual rehabilitation is generally faster after EK than after PK.2,18 Our findings suggest that a similar trend toward earlier recovery may also be present in late elderly patients. However, whether such early improvement leads to meaningful functional benefits, such as better ADL or QOL, remains uncertain and warrants further investigation. In summary, this study demonstrated that endothelial keratoplasty (EK) for bullous keratopathy in late elderly patients provides rapid postoperative visual recovery with efficacy and safety comparable to those in younger patients. Our subgroup analysis also suggested that nDSAEK may offer favorable graft survival in the elderly population; however, this finding should be regarded as exploratory due to small sample size and baseline imbalances. Overall, EK—including both DSAEK and nDSAEK—should be considered a valuable treatment option for elderly patients, contributing to improved visual function, maintenance of daily activity, and overall quality of life in an aging society. Disclosure M. Hirayama, R Hokama, T Suzuki, and K Negishi declare that they have no conflicts of interest. References